Adaptive Stent Graft Devices for Optimized Fluid Flow and Biocompatibility

The inventive concept envisions a next-generation stent graft device that adaptively adjusts its geometry in response to changes in bodily conduit morphology, optimizing fluid flow and minimizing the risk of tissue ingrowth. This paradigm shift enables personalized, real-time therapeutic interventions and sets a new standard for implantable medical devices.

The original patent for implantable intraluminal devices addressed the need for stent graft devices that can be implanted in bodily cavities, organs, and vessels. However, these devices often face limitations in terms of flexibility, tissue ingrowth, and fluid flow optimization. The new inventive concept tackles these limitations by introducing adaptive, modular, and biohybrid components that dynamically respond to changing physiological conditions.

The adaptive stent graft device comprises a modular, self-expanding framework that adjusts its geometry in response to changes in bodily conduit morphology. This is achieved through a network of sensors and actuators that collaborate to optimize fluid flow and detect potential complications. The device can be deployed through minimally invasive procedures and subsequently programmed to dynamically adjust its shape and fluid flow characteristics in response to real-time physiological feedback. Interchangeable, 3D-printed segments can be customized to accommodate unique anatomical features and adapt to changing physiological conditions over time. Furthermore, the integration of living tissue components with synthetic materials enables the device to actively promote tissue regeneration, mitigate inflammation, and enhance overall biocompatibility.

The new inventive concept's adaptive, modular, and biohybrid components, as well as its ability to dynamically respond to changing physiological conditions, represent a significant departure from the original patent's fixed, tubular design. The integration of real-time physiological feedback, 3D-printed segments, and living tissue components introduces a new level of sophistication and personalization in implantable medical devices.

Alternative embodiments of the inventive concept could include devices with varying levels of adaptivity, different sensor and actuator configurations, or alternative materials and manufacturing techniques. Variations could also include devices tailored to specific anatomical locations or patient populations, such as pediatric or geriatric patients.

The adaptive stent graft device has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular, neurovascular, and peripheral vascular interventions. The device's ability to optimize fluid flow and minimize tissue ingrowth could reduce complications and improve patient outcomes, making it an attractive solution for healthcare providers and patients alike.